[1] FEETHAM L, VAN DA.Chronic obstructive pulmonary disease (COPD)[J].Lancet Pespir Med, 2017, 5(1):18. doi: 10.1016/S2213-2600(16)30442-8
[2] LIU X, FANG Q, KIM H.Preclinical studies of mesenchymal stem cell (MSC) administration in chronic obstructive pulmonary disease (COPD):A systematic review and Meta-analysis[J].PLoS One, 2016, 11(6):e0157099.
[3] MARCOA R, RODRIGUES DM, DIAS M, et al.Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017:Comparison with GOLD 2011[J].COPD, 2018, 15(1):21. doi: 10.1080/15412555.2017.1394285
[4] 中华医学会呼吸病学分会慢性阻塞性肺疾病学组.慢性阻塞性肺疾病诊治指南(2013年修订版)[J/CD].中国医学前沿杂志: 电子版, 2014, 6(2): 67.
[5] 慢性阻塞性肺疾病急性加重诊治专家组.慢性阻塞性肺疾病急性加重(AECOPD)诊治中国专家共识(草案)[J/CD].中华哮喘杂志: 电子版, 2013, 32(1): 541.
[6] RICHARDS JB.iCalculated decisions:mMRC (Modified Medical Research Council) Dyspnea Scale[J].Emerg Med Pract, 2017, 19(Suppl 10):1.
[7] KASTELEYN M, ESQUINAS C, BARRECHEGUREN M, et al.Identifying cut off scores for the chronic obstructive pulmonary disease assessment test (CAT) to predict exacerbations in COPD[C]//Ers International Congress, 2017: OA2918.
[8] 陈云坤, 冯英凯.GOLD 2017新版指南要点解读[J].现代医药卫生, 2017, 33(4):481. doi: 10.3969/j.issn.1009-5519.2017.04.001
[9] ROFFMAN CE, BUCHANAN J, ALLISON GT.Charlson Comorbidities Index[J].J Physiother, 2016, 62(3):171. doi: 10.1016/j.jphys.2016.05.008
[10] RAMEZANI M, AMINPARAST Z, ASDEGHI M.Pulmonary alveolar microlithiasis and interstitial pneumonitis:a case report of the west of Iran[J].Biomedicine, 2019, 9(4):28. doi: 10.1051/bmdcn/2019090428
[11] KOCHETOVA EV.Assessment of comorbidity of comorbidity in those suffering from chronic obstructive pulmonary disease abstract[J].Tuberculosis, 2017, 95(4):11.
[12] DURSUNOGLU N, KOKTURK N, BAHA A, et al.Comorbidities and their impact on chronic obstructive pulmonary disease[J].Tuberkuloz Ve Toraks, 2016, 64(4):289. doi: 10.5578/tt.2245
[13] 张霖, 皮春梅, 聂秀红.查尔森合并症指数对老年慢性阻塞性肺疾病患者预后的评估价值[J].中国呼吸与危重监护杂志, 201615(4):333.
[14] FABBIAN F, DE GA, MANFREDINI, et al.Impact of renal dysfunction on in-hospital mortality of patients with severe chronic obstructive pulmonary disease:a single-center Italian study[J].Int Urol Nephrol, 2016, 48(7):1.
[15] BAUMAN TM, POTRETZKE AM, VETTER JM, et al.Cerebrovascular disease and chronic obstructive pulmonary disease increase risk of complications with robotic partial nephrectomy[J].J Endourol, 2016, 30(3):212.
[16] RONCERO C, CAMPUZANO AI, QUINTANO JA, et al.Cognitive status among patients with chronic obstructive pulmonary disease[J].Int J Behav Med, 2016, 11(1):543.
[17] 李翠君, 盘德辉, 欧阳细瑜.慢性阻塞性肺疾病急性加重期患者近期预后的危险因素分析[J].海南医学, 2018, 29(8):1076. doi: 10.3969/j.issn.1003-6350.2018.08.012
[18] LOH CH, PETERS SP, LOVINGS TM, et al.Suboptimal inspiratory flow rates are associated with chronic obstructive pulmonary disease and all cause readmissions[J].Ann Am Thorac Soc, 2017, 14(8):1305. doi: 10.1513/AnnalsATS.201611-903OC
[19] 胡旭, 靳开宇, 范贤明.慢性阻塞性肺疾病合并支气管扩张的发病机制、诊断与治疗研究进展[J].山东医药, 2016, 56(31):106.